Surfactant metabolism dysfunction

From WikiMD's WELLNESSPEDIA


Surfactant metabolism dysfunction
Synonyms Surfactant deficiency disorder
Pronounce N/A
Specialty N/A
Symptoms Respiratory distress, hypoxemia, cyanosis
Complications Respiratory failure, pulmonary hypertension
Onset Neonatal period
Duration Chronic
Types N/A
Causes Genetic mutations in surfactant proteins
Risks Premature birth, family history
Diagnosis Genetic testing, chest X-ray, lung biopsy
Differential diagnosis Neonatal respiratory distress syndrome, bronchopulmonary dysplasia
Prevention N/A
Treatment Surfactant replacement therapy, oxygen therapy, mechanical ventilation
Medication Corticosteroids, antibiotics
Prognosis Variable, depends on severity and treatment
Frequency Rare
Deaths N/A


Surfactant Metabolism Dysfunction is a genetic disorder that affects the lungs. It is characterized by the inability of the body to produce or process surfactant, a substance that is essential for normal lung function. This disorder can lead to a variety of respiratory problems, including respiratory distress syndrome and interstitial lung disease.

Causes[edit]

Surfactant Metabolism Dysfunction is caused by mutations in certain genes that are involved in the production or processing of surfactant. These genes include ABCA3, SFTPB, SFTPC, and SFTPD. The mutations can be inherited from one or both parents.

Symptoms[edit]

The symptoms of Surfactant Metabolism Dysfunction can vary widely, but they generally include difficulty breathing, cough, and wheezing. In severe cases, the disorder can lead to life-threatening respiratory failure.

Diagnosis[edit]

Diagnosis of Surfactant Metabolism Dysfunction typically involves a combination of medical history, physical examination, and laboratory tests. These tests may include genetic testing to identify mutations in the genes associated with the disorder.

Treatment[edit]

Treatment for Surfactant Metabolism Dysfunction is primarily supportive and aims to manage the symptoms. This may include oxygen therapy, mechanical ventilation, and medications to help improve lung function.

Prognosis[edit]

The prognosis for individuals with Surfactant Metabolism Dysfunction can vary widely. Some individuals may have a relatively mild course of the disease, while others may experience severe respiratory problems that can be life-threatening.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.